• Pharma
  • May 9, 2025
  • 158 views
Biocon Q4 net profit surges 153%, biosimilars, generics drive growth

Biocon, India’s leading biopharmaceutical company, reported a 153 percent year-on-year (YoY) jump in net profit for the fourth quarter of FY25, led by strong performances in its biosimilars and generics…